Skip to main content

Christopher M. Blanchette, PhD, MBA

Authored Items
Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States
Michael C. Runken, PharmD, Gary M. Owens, MD, Joshua M. Noone, PhD, Christopher M. Blanchette, PhD, MBA, Emily Zacherle, MS, Reuben Howden, PhD
October 2019 Vol 12, No 6 in Original Research, Practice Management
Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend
Christopher M. Blanchette, PhD, MBA, Nicholas J. Gross, MD, PhD, Pablo Altman, MD, MBA, F. Randy Vogenberg, PhD, FASHP
April 2014 Vol 7, No 2 in Practice Management
Last modified: October 16, 2019